Other TKIs

PreclinicalSmall molecule

Bayer

Other TKIs is one of 56 small molecule programs targeting Thyroid Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Thyroid CancerActive, not recruiting

COVID-19Active, not recruiting

Thyroid CancerPreclinical

Active, not recruiting

COVID-19Preclinical

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

COVID-19 Vaccine

Moderna

Preclinical

27 2

Aldactone

Pfizer

Preclinical

1 3

Nexavar

Bayer

Preclinical

1 4

Calciferol

Alnylam Pharmaceuticals

Benadryl

1 6

SARS-COV-2 VACCINE

Moderna

Preclinical

2 7

Blood Taken

HHospices Civils de Lyon

Preclinical

1 8

Vit D

PPost Graduate Institute of Medical Education and Research, Chandigarh

Preclinical

1 9

Hydroxychloroquine Pill

UUniversity of Calgary

Preclinical

2 10

Disease-Modifying Anti-Rheumatic Drugs

Roche

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Rivaroxaban2 trials

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Completed· Bayer logo

Bayer··NCT05112666·2,601 enrolled

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Completed· Bayer logo

Bayer··NCT05150938·5,737 enrolled

Oral1 trial

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

Completed· Bayer logo

Bayer··NCT00988910·632 enrolled

Thyroid Cancer1 trial

An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors

Completed· Bayer logo

Bayer··NCT02303444·667 enrolled

COVID-191 trial

An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib

Completed· Bayer logo

Bayer··NCT05594147·4,103 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Other TKIs. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Other TKIs compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Other TKIs. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bayer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Bayer

Other TKIs

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Rivaroxaban2 trials

Oral1 trial

Thyroid Cancer1 trial

COVID-191 trial

References

Drug Info

Quick Facts

Related News